KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Net Cash Flow (2016 - 2026)

Supernus Pharmaceuticals has reported Net Cash Flow over the past 15 years, most recently at -$22.9 million for Q4 2025.

  • Quarterly Net Cash Flow fell 160.87% to -$22.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $60.6 million through Dec 2025, up 1158.31% year-over-year, with the annual reading at $60.6 million for FY2025, 1158.31% up from the prior year.
  • Net Cash Flow was -$22.9 million for Q4 2025 at Supernus Pharmaceuticals, down from $8.1 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $369.1 million in Q1 2023 and troughed at -$437.5 million in Q2 2023.
  • The 5-year median for Net Cash Flow is -$11.8 million (2021), against an average of -$7.9 million.
  • The largest YoY upside for Net Cash Flow was 520.75% in 2023 against a maximum downside of 858.05% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at -$11.8 million in 2021, then crashed by 55.08% to -$18.4 million in 2022, then dropped by 8.49% to -$19.9 million in 2023, then surged by 288.94% to $37.7 million in 2024, then crashed by 160.87% to -$22.9 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Net Cash Flow are -$22.9 million (Q4 2025), $8.1 million (Q3 2025), and $28.9 million (Q2 2025).